Delivery Order SPE2DB22D1106-SPE2DB25FFGM1
- Not listed
- The Defense Logistics Agency awarded a $35,787.10 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 10 mg/0.5 ml pens. The contract represents a firm fixed price, competitively awarded delivery order with a completion date of August 20, 2025, and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a ceiling value of $2,890.34. This is a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is non-competitive and represents a single delivery order under the company's larger indefinite delivery contract vehicle...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $16,313.49 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with a completion date of August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $4,132.19 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. This delivery order represents a single transaction...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a contract value of $15,251.60. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 12, 2025, with the place of performance located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $32,686.96. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,410.85 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on September 15, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's established capability to...
- The Defense Logistics Agency awarded a $5,341.80 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a completion date of September 9, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGM1Delivery Order
The Defense Logistics Agency awarded a $4,074.44 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This non-set-aside, firm fixed-price contract is set to be completed by September 4, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the broader federal pharmaceutical supply framework managed by AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The Zepbound delivery exemplifies the company's role in providing specialized medications across multiple therapeutic domains to federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/3/25 |